Webinars - Orygen, Revolution in Mind

Webinars

Neuroscience of anxiety disorders (April 2017)

This advanced practice webinar will provide an overview on brain functioning and anxiety disorders in young people. It will explore psychological and neuroscience perspectives to understanding threat, fear and the brain. The webinar will present recent findings from neuroimaging studies, with a focus on functional magnetic resonance imaging results, as relevant to anxiety disorders. In exploring how the brain supports emotion and affect, this webinar will also include a focus on the relevance of neuroscience to clinical practice.

Social anxiety, stigma and early psychosis (March 2017)

This webinar will describe social anxiety, its prevalence in early psychosis and its relationship to the stigma of psychosis. Relevant research evidence that explores the relationship between social anxiety, paranoid symptoms, negative beliefs about the self and the experience of shame will be presented. The webinar will explore treatment approaches for social anxiety in early psychosis that aim to assist young people to recover their quality of life and improve psychosocial functioning.

Social Anxiety: Overview of the evidence for treating young people (March 2017)

This webinar will examine the latest evidence for treating young people with social anxiety disorder, focusing on psychological treatments. The webinar will explore the prevalence and characteristics of social anxiety in young people, how social anxiety presents in young people and the common comorbid conditions. In reviewing the latest evidence for psychological treatments, the webinar will also describe and explore the components of these treatments with specific focus on cognitive and cognitive behavioural therapies. Any differences in treatment outcomes depending on whether the psychological interventions are delivered in group-based or individual formats will also be considered. This webinar will provide a useful summary of the most effective psychological interventions for treating social anxiety disorder in young people.